This paper is only available as a PDF. To read, Please Download here.
Abstract
Saccadic distractibility, Stroop color-word scores, and serial dyskinesia assessments
were obtained on 10 schizophrenic patients with tardive dyskinesia during a pharmacologic
challenge with placebo or 7 mg muscimol, a potent, direct-acting GABA agonist. Although
no significant difference in the measures was evident between conditions, a significant
correlation was found between GABA agonist-induced changes in saccadic distractibility
and dyskinesia scores where no correlation existed between these measures on placebo.
Improvement in saccadic distractibility was also correlated with reduction in attention
performance, as measured by Stroop. These effects are not due to sedation. The correlation
between dyskinesia and saccadic distractibility is consistent with a model of parallel
motor and oculomotor cortico-striatal-thalamic circuits in humans. This work supports
the hypothesis that a dysfunction in GABA-mediated neurotransmission may be the basis
for tardive dyskinesia.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Biological PsychiatryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Functional architecture of basal ganglia circuits: neural substrates of parallel processing.Trends in Neuroscience. 1990; 13: 266-271
- Parallel organization of functionally segregated circuits linking basal ganglia and cortex.Ann Rev Neurosci. 1986; 9: 357-381
- The structure of muscimol, a GABA analogue of restricted conformation.Acta Chem Scand. 1972; 26: 1359-1361
- Gamma-acetylenic GABA in tardive dyskinesia.Arch Gen Psychiatry. 1980; 37: 1376-1379
- Primate models of movement disorders of basal ganglia origin.Trends in Neurosci. 1990; 13: 281-285
- The Design and Analyses of Clinical Experiments.Wiley, New York1986
- Chronic blockade of dopamine receptors by antischizophrenic drugs enhances GABA binding in substantia nigra.Nature. 1980; 283: 569-570
- Stroop Color and Word Test: A Manual for Clinical and Experimental Uses.in: Stoelting, Chicago1978
- Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis.Nature. 1984; 309: 347-349
- Effects on eye movements of a GABA agonist and antagonist injected into monkey superior colliculus.Brain Res. 1983; 272: 368-372
- Modification of saccadic eye movements by GABA-related substances. I. Effects of muscimol and bicuculline in monkey superior colliculus. II. Effect of muscimol in monkey substantia nigra pars reticulata.J Neurophysiol. 1985; 53: 266-308
- The Neurology of Eye Movements.ed 2. FA Davis Company, Philadelphia1991
- A quantitative investigation of the substantia nigra in Huntington's disease.Ann Neuro. 1989; 26: 13-19
- The anterior cingulate cortex mediates processing selection in the Stroop attentional conflict paradigm.in: Proc Natl Acad Sci USA. 87. 1990: 256-259
- Dopamine-GABA interactions: Evidence that GABA transmits, modulates, and mediates dopaminergic functions in the basal ganglia and the limbic system.Acta Neurol Scan. 1986; 73: 1-54
- Research diagnosis for tardive dyskinesia.Arch Gen Psych. 1982; 39: 486-487
- History of neuroleptic drugs and tardive dyskinesia.in: Fann W.E. Smith R.C. Davis J.M. Tardive Dyskinesia: Research and Treatment. SP Medical & Scientific Books, Jamaica, NY1980
- Muscimol: GABA agonist therapy in schizophrenia.Am J Psychiatry. 1978; 135: 746-747
- Improvement in tardive dyskinesia after muscimol therapy.Arch Gen Psychiatry. 1979; 36: 595-598
- Tardive Dyskinesia: GABA Agonist Treatment.in: Catecholamines: Neuropharmacology and Central Nervous System—Therapeutic Aspects. 1984: 69-72
- GABAmimetic drugs in hyperkinetic involuntary movement disorders and their effects on mental status.Drug Dev Res. 1990; 21: 227-233
- Brain gamma-aminobutyric acid abnormality in tardive dyskinesia.Arch Gen Psychiatry. 1987; 44: 522-529
- Increased saccadic distractibility in tardive dyskinesia: Functional evidence for subcortical GABA dysfunction.Biol Psychiatry. 1989; 25: 49-59
- Tobacco smoking increases square-wave jerks during pursuit eye movements.Biol Psychiatry. 1991; 29: 82-88
Article info
Publication history
Received in revised form:
April 7,
1992
Received:
November 16,
1991
Footnotes
☆An abstract of this work was presented at the International Congress on Schizophrenia Research, Tucson, AZ 1991.
☆☆This work was supported in part by National Institute of Mental Health grants MH 43031, MH 37073, MH 18914, and P50-MH 40279.
Identification
Copyright
© 1992 Published by Elsevier Inc.